Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
Bayer
AstraZeneca
Sun Yat-sen University
GlaxoSmithKline
OHSU Knight Cancer Institute
AstraZeneca
University of Cologne
Eli Lilly and Company
European Organisation for Research and Treatment of Cancer - EORTC
Puma Biotechnology, Inc.
University Hospital, Saarland